September 20, 2016
ropeginterferon

Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera

Key points The novel IFNα-2b AOP2014 administered once every two weeks (or once a month) has low toxicity and induces high and sustained response rates in […]
August 30, 2016
Understanding the JAK2 mutation

Understanding the JAK2 Mutation

THE STORY OF JAK2 Four teams race to find the mysterious cause of a group of blood cancers. Click the link below for the complete article…
August 28, 2016
Frequency of MPN in Korea

Incidence, Survival and Prevalence Statistics of Classical Myeloproliferative Neoplasm in Korea

J Korean Med Sci. 2016 Oct;31(10):1579-1585. English. Published online Jul 22, 2016.  http://dx.doi.org/10.3346/jkms.2016.31.10.1579 © 2016 The Korean Academy of Medical Sciences. Incidence, Survival and Prevalence Statistics of […]
August 17, 2016
CRISPR being studied for cancer treatment

Scientists are going to use CRISPR on humans next month to try and cure cancer

Scientists in China are about to become the first to use the game-changing gene-editing technology Crispr-Cas9 on humans. Last week, Nature reported that researchers at Sichuan […]
August 16, 2016

Bone Marrow transplant without using chemo – Scientists create a safer way

Scientists have devised a way to destroy blood stem cells in mice without using chemotherapy or radiotherapy, both of which have toxic side effects. Blood stem […]
August 15, 2016
physical activity beneficial for MPNs

Physical Activity a Nonpharmacological Approach in Symptom Management in Myeloproliferative Neoplasms

Conclusions: MPN patients are understudied and there are currently no studies that have explored the effects of physical activity on sympton burden and QoL in these […]
Do NOT follow this link or you will be banned from the site!
Malcare WordPress Security